VOYA INVESTMENT MANAGEMENT LLC - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 144 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$165,000
-25.3%
43,3660.0%0.00%
Q4 2019$221,000
+20.8%
43,366
+19.5%
0.00%
Q3 2019$183,000
-18.3%
36,2920.0%0.00%
Q2 2019$224,000
+32.5%
36,292
-0.5%
0.00%
Q1 2019$169,000
+10.5%
36,4800.0%0.00%
Q4 2018$153,000
-22.3%
36,480
+16.4%
0.00%
Q3 2018$197,000
-18.3%
31,348
+4.6%
0.00%
-100.0%
Q2 2018$241,000
-3.6%
29,964
-10.5%
0.00%0.0%
Q1 2018$250,000
+17.9%
33,494
-6.1%
0.00%
Q4 2017$212,000
-19.1%
35,6570.0%0.00%
-100.0%
Q3 2017$262,000
+8.3%
35,6570.0%0.00%0.0%
Q2 2017$242,000
-19.3%
35,657
+12.4%
0.00%0.0%
Q1 2017$300,000
+9.5%
31,7370.0%0.00%0.0%
Q4 2016$274,000
+36.3%
31,7370.0%0.00%
Q3 2016$201,000
+50.0%
31,7370.0%0.00%
Q2 2016$134,000
-2.9%
31,7370.0%0.00%
Q1 2016$138,000
-29.2%
31,7370.0%0.00%
Q4 2015$195,000
+7.1%
31,7370.0%0.00%
Q3 2015$182,000
-40.1%
31,737
-22.2%
0.00%
-100.0%
Q2 2015$304,000
+12.6%
40,813
-9.6%
0.00%0.0%
Q1 2015$270,000
-20.8%
45,1410.0%0.00%0.0%
Q4 2014$341,000
+45.7%
45,1410.0%0.00%0.0%
Q3 2014$234,000
+20.0%
45,1410.0%0.00%
Q2 2014$195,000
+5.4%
45,1410.0%0.00%
Q1 2014$185,000
-23.2%
45,1410.0%0.00%
-100.0%
Q4 2013$241,000
+6.2%
45,1410.0%0.00%0.0%
Q3 2013$227,000
+12.9%
45,1410.0%0.00%0.0%
Q2 2013$201,00045,1410.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q2 2019
NameSharesValueWeighting ↓
EVERENCE CAPITAL MANAGEMENT INC 28,980$123,0000.01%
Daiwa Securities Group Inc. 533$2,0000.00%
IFP Advisors, Inc 0$00.00%
NEW YORK STATE TEACHERS RETIREMENT SYSTEM 138,663$52,0000.00%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders